StewartJ.TepperMD

PubMed

• Eptinezumab treatment was associated with longer interictal headache/migraine periods which corresponded to greater improvements in patient-reported quality of life me...
  Stewart J Tepper, Merle L Diamond, Joe Hirman, Divya Asher, Damian Fiore
  Journal of Neurology. 2024-12-12
• Long-Term (12-Month) Safety and Tolerability of STS101 (Dihydroergotamine Nasal Powder) in the Acute Treatment of Migraine: Data from the Phase 3 Open-Label ASCEND Study.
  Stewart J Tepper, Detlef Albrecht, Jessica Ailani, Louis Kirby, Shannon Strom
  CNS Drugs. 2024-12-01
• Efficacy and Safety of Erenumab for Nonopioid Medication Overuse Headache in Chronic Migraine: A Phase 4, Randomized, Placebo-Controlled Trial.
  Stewart J Tepper, David W Dodick, Michel Lanteri-Minet, David Dolezil, Raquel Gil-Gouveia
  JAMA Neurology. 2024-09-16

Journal Articles

• Anti‐Calcitonin Gene‐Related Peptide (CGRP) Therapies: Update on a Previous Review After the American Headache Society 60th Scientific Meeting, San Francisco, June 2018  
  Stewart Tepper, MD, Headache: The Journal of Head and Face Pain
• Improving Medical Communication in Migraine Management: A Modified Delphi Study to Develop a Digital Migraine Tracker  
  Dawn C Buse, Stewart J Tepper, David W Dodick, Richard B Lipton, Headache: The Journal of Head and Face Pain
• Migraine: barriers for care.  
  Sheftell FD, Tepper SJ, Bigal ME, Neurol Sci. 2005;26 Suppl 2:s140-2
• Strategies of Care for Acute Treatment of Migraine.  
  Tepper SJ, Rapoport AM, Sheftell FS, The Journal of Headache and Pain 2003;3:63-69
• Which triptan for which patient?  
  Rapoport AM, Tepper SJ, Sheftell FD, Kung E, Bigal ME, Neurol Sci. 2006; 27 Suppl 2:s123-9
• Role of melatonin in the pathophysiology of migraine: implications for treatment.  
  Vogler B, Rapoport AM, Tepper SJ, Sheftell F, Bigal ME, CNS Drugs 2006;20:343-350
• Poor Response to One Triptan No Predictor of Response to Others.  
  Tepper SJ, Journal Watch Neurology 2006;8:49
• Migraine- The Forgotten Epidemic: Development of the EHF/WHA Rome Declaration on Migraine.  
  Diener H-C, Steiner TJ, Tepper SJ, J Headache and Pain 2006;7:1-5
• Trigger Points and Chronic Tension-type Headache.  
  Tepper SJ, Journal Watch Neurology 2007;9:5
• The Patent Foramen Ovale-Migraine Question.  
  Tepper SJ, Sheftell FD, Bigal ME, Neurol Sci 2007;28:S118–S123
• Post-traumatic headache: emphasis on chronic types following mild closed head injury.  
  Sheftell FD, Tepper SJ, Lay CL, Bigal M, Neurol Sci 2007;28:S203-S207
• Migraine Prevalence and Disease Burden.  
  Tepper SJ, Journal Watch Neurology 2007;9:50-51
• Headache Attributed to Hypothryoidism.  
  Tepper DE, Tepper SJ, Sheftell FD, Bigal ME, Current Pain and Headache Reports 2007;11:304-309
• Acute Treatment of Menstrual Migraine.  
  Tepper SJ, Current Pain and Headache Reports 2007;6:169-173
• Is It Sinus Headache or Migraine?  
  Tepper SJ and Stillman MJ, Journal Watch Neurology 2008; 10:36-37
• Serotonin syndrome risks when combining SSRI/SNRI drugs and triptans: literature review and recommendations.  
  Wenzel RG, Tepper S, Korab WE, Freitag F, Annals of Pharmacotherapy 2008;42(11):1692-6
• Facial Pain and Trigeminal Trophic Syndrome.  
  Kriegler J and Tepper SJ, Journal Watch Neurology 2008;10:92-93
• Key Points in Migraine Prophylaxis: Patient Perspective.  
  D’Amico D and Tepper SJ, Neurol Sci 2009; 30 (Suppl 1):S39–S42
• Telcagepant, a calcitonin gene-related peptide antagonist for the treatment of migraine.  
  Tepper SJ and Cleves C, Current Opinion in Investigational Drugs 2009; 10(7):711-720
• Medication Overuse Headache: Breaking the Cycle.  
  Tepper SJ and Tepper DE, Cleveland Clinic Journal of Medicine 2010; 77(4):236-242
• Biofeedback for Migraine and Tension-Type Headache.  
  Baron EP and Tepper SJ, Journal Watch Neurology 2010;12(5):39
• Defining New Daily-Persistent Headache.  
  Kelley NE and Tepper SJ, Journal Watch Neurology 2010 Nov;12 (11):85
• Unusual Headaches in the Elderly.  
  Bamford CC, Mays M, Tepper SJ, Curr Pain Headache Rep. 2011; 15(4):295-301
• Reversible Anorgasmia with Topiramate Therapy for Headache: A Report of 7 Patients.  
  Sun C, Lay C, Broner S, Silberstein S, Tepper S, Newman L, Headache 2006; 46:1450-1453
• A misleading cervical bruit in carotid occlusion.  
  Mullally WJ, Tepper SJ, Walshe TM 3rd, Wang AM, Samuels MA, N J Med. 1988 Jun;85(6):519-21
• Join now to see all

Books/Book Chapters

• Current Diagnosis and Treatment of Pain. 
  Chapter: Headaches 
  Page 150 - 171Volcy M and Tepper SJEditors: Von Roenn JV, Preodor ME, Paice JA.McGraw-Hill, NY
• Cleveland Clinic Manual of Headache Therapy. 
  Tepper SJEditors: Tepper SJ and Tepper DE.Springer Publishing, New York
• Conquering Daily Headache. 
  Rapoport AM, Sheftell FD, Blumenfeld A, and Tepper SJB.C. Decker Inc Publisher, Hamilton, Ontario
• Advanced Therapy of Headache. 
  Tepper SJEditors: Purdy RA, Tepper SJ, Rapoport AM, Sheftell FD.BC Decker Inc, Hamilton, Ontario, LondonEdition 2,
• Conquering Headache. 
  Rapoport AM, Sheftell FD, Tepper SJDecker DTC, Hamilton, Ontario, LondonEdition 5,
• Understanding Migraine and Other Headaches. 
  Tepper SJUniversity of Mississippi Press, Jackson, MI
• Conquering Headache. 
  Rapoport AM, Sheftell FD, Tepper SJB.C. Decker Inc Publisher, Hamilton, OntarioEdition 4,
• The Spectrum of Migraine. 
  Tepper SJ, Rapoport AM, Sheftell FDMcMahon Publishing, New York
• Conquering Headache. 
  Rapoport AM, Sheftell FD, Tepper SJB.C. Decker Inc Publisher, Hamilton, OntarioEdition 3,
• Handbook of Clinical Neurology. 
  Chapter: The Role of Prevention 
  Page 195 - 205Tepper SJEditors: Aminoff M, Nappi G and Moskowitz M.Elsevier, NYEdition 3,
• Refractory Migraine. 
  Chapter: Medication Overuse Headache, in Refractory Headache and Its Treatment 
  Page 136 - 159Tepper SJ and Tepper DEEditors: Schulman EA, Levin M, Lake AE and Loder E.Oxford University Press, NY
• Migraine and other Primary Headaches, Neurologic Clinics. 
  Chapter: Acute Treatment of Migraine 
  Tepper SJ and Spears RCEditors: Evans, R.Elsevier, NY
• The Headache Cooperative of New England Comprehensive Review of Headache Medicine. 
  Chapter: Preventive Pharmacologic Treatment of Migraine and Tension-type Headache 
  Page 231 - 254Tepper SJEditors: Levin M.Oxford University Press, Oxford
• Headache in Children and Adolescents. 
  Chapter: Complementary and Alternative Treatments for Childhood Headaches 
  Page 283 - 295Tepper SJ and Koch TKEditors: Winner P.BC Decker, Hamilton, Ontario
• Biological Psychiatry Today, Vol. 2. 
  Chapter: Cholinergic Aspects of Tardive Dyskinesia 
  Casey DE, Tepper SJEditors: Obiols J, Ballus C, Gonzalezmonclus E, Pujol J.Elsevier North Holland Biomedical Press
• Head, Neck and Facial Pain: A Case-based Handbook of Diagnosis, Management, and Prognosis. 
  Chapter: Chronic Daily Headache 
  Page 25 - 29Tepper SJEditors: Levin M and Ward TN.Anadem Publishing, Columbus, Ohio
• Current Diagnosis and Treatment of Pain. 
  Chapter: Headaches 
  Page 150 - 171Volcy Gomez M and Tepper SJEditors: Von Roenn JH, Paice JA, Preodor ME.Lange Medical Books/McGraw-Hill, New York
• The Headaches. 
  Chapter: Headache Associated with Acute Substance Use or Exposure 
  Page 959 - 969Pereira Monteiro JMP, Tepper S, Shapiro REEditors: Olesen J, Goadsby P, Ramadan N, Tfelt-Hansen P, Welch MA.Lippincott Williams and Wilkins, Philadelphia
• Migraine and Other Headache Disorders. 
  Chapter: Nonspecific Migraine Acute Treatment 
  Page 273 - 288Krymchantowski A and Tepper SJEditors: Lipton RB and Bigal ME.Informa Healthcare
• Advanced Therapy of Headache. 
  Chapter: The Woman with Never-Ending Headaches 
  Page 109 - 112Bigal ME, Rapoport AM, Sheftell FD, Tepper SJEditors: Purdy RA, Tepper SJ, Rapoport AM, Sheftell FD.BC Decker Inc, Hamilton, Ontario, LondonEdition 2,
• Encyclopedia of the Neurological Science. 
  Chapter: Coital Headache 
  Page 510 - 511Tepper SJ and Rapoport AMEditors: Aminoff M and Daroff R.Academic Press, San Diego
• Book Review: The Triptans: Novel Drugs for Migraine. 
  Page 1 - 134Tepper SJEditors: Humphrey P, Ferrari M, and Olesen J.
• Book Review: Management of Headache and Headache Medications. 
  Page 55 - 1425Tepper SJ, Rapoport AMEditors: Robbins, L.Edition 2,
• Advanced Therapy of Headache. 
  Chapter: The Woman Who Could Not Decide Which Medicine to Take 
  Sheftell, FD, Rapoport, AM, Purdy A, Tepper SJEditors: Rapoport, AM, Purdy A, Sheftell FD.B.C. Decker Inc Publisher, Hamilton, Ontario
• Advanced Therapy of Headache. 
  Chapter: The Woman with Right Upper Facial Pain 
  Page 271 - 276Tepper SJEditors: Rapoport AM, Purdy A, Sheftell FD.B.C. Decker Inc, Hamilton, OntarioEdition 1,
• Join now to see all

Abstracts/Posters

• Botulinum Toxin in the Preventive Treatment of Refractory Headaches.
  Tepper SJ, Bigal ME, Sheftell FD, Rapoport AM, International Headache Research Seminars, Copenhagen, Denmark
• Short-lasting unilateral neuralgiform headache attacks with cranial autonomic symptoms (SUNA)—a case report.
  Volcy M, Tepper SJ, Rapoport AM, Sheftell FD, Bigal MD, Cephalalgia 2005:25:470–472
• Rational Therapy for Headache.
  Cady RK, Rosum RW, Solomon GD, Tepper SJ, Institute for Contemporary Pharmacy Research
• First-line treatment for migraine: analgesics or triptans; Migraine-specific versus nonspecific treatment.
  Tepper SJ, American Council on Headache Education Newsletter 2000;11(issue 2):1,6
• A Multidisciplary Approach to Treating Menstrual Migraine: An Algorithm for Short-term Prevention.
  Newman LC, Cady RK, MacGregor EA, Shulman LP, Hutchinson SL, Martin VT, Silberstein SD, Tepper SJ, University of Cincinnati and IMED Communications. Califon, NY: IMED Communications
• Prophylaxis of Migraine: General Principles and Patient Acceptance.
  D’Amico D and Tepper SJ, Neuropsychiatric Disease and Treatment 2008:4(6) 1–13
• Repetitive Outpatient Oral Sumatriptan in Detoxification for Patients with Transformed Migraine with Medication Overuse.
  Drucker P, Tepper SJ, Headache. 1997; 37:307-308
• Overview of the Clinical Response to Zolmitriptan in Migraineurs Identified as 'Poor Responders' to Other Migraine Preparations.
  Winner P, Sheftell F, Ryan R, Tepper SJ, Headache. 1997:37:336-337
• Zolmitriptan ('Zomig', 311C90) is Efficacious in Migraine on Awakening.
  Tepper SJ, Millson DS, J Neuological Sciences. 1997;150:S106
• Clinical effectiveness of 'Zomig' (Zolmitriptan, 311C90) in established migraine (>=4hours pretreatment duration).
  Solomon GD, Sheftell FD, Tepper SJ, J Am Osteopathic Ass. 1997;97:489
• Patient-reported Tablet Utilization of Zolmitriptan and Sumatriptan.
  Tepper S, Ward T, Maurer C, Headache. 1998; 38: 408-409
• The new triptans (5-HT 1B/1D agonists for acute treatment of migraine: a clinical review using number needed to treat (NNT) analysis.
  Tepper SJ, Millson D, European Journal of Neurology 1998; 5 (Suppl 3):S55
• Efficacy and safety of gabapentin (Neurontin) in Migraine Prophylaxis.
  Saper J, Podolnick P, Klapper J, Tepper S, Stacey B, Rapoport A, Ramadan N, Cephalalgia 1999; 19:380
• Issues relating to the assessment of migraine recurrence following triptan therapy.
  Millson D and Tepper S, European Journal of Neurology 1999; 6:1-2
• therapeutic benefit of rizatriptan compared with eletriptan
  Tepper SJ, Allen CP, Vandormael K, Cephalalgia 2000;20:355, and Eur J Neurology 2000 7(Suppl 3):86
• Number Needed to Treat Depends on Placebo Response Rate.
  Sheftell FD, Weeks RE, Tepper SJ, Fox AW, Cephalalgia 2000;20:323
• Validation of the headache impact test using patient-reported symptoms and headache pain severity.
  Ware, JE, Kosinski M Diamond M, Bayliss MB, Tepper S, Dowson A, Batenhorst AS, Cephalalgia 2000;20:320
• Reducing the cost of impairment of Normal Activities due to Migraine: A Stratified-Care Approach.
  Tepper SJ, Meddis D, Headache 2000; 40:434-435
• HIT-6 Scores Discriminate Among Headache Sufferers Differing in Headache-Associated Workplace Productivity Loss.
  Bayliss MS, M Kosinski M, Diamond M, Tepper S, Garber WH, Ware J, Batenhorst A, Neurology 2001;56 (Suppl 3):A139
• A double-blind, placebo-controlled study to investigate the efficacy and tolerability of intravenous 1.2 mg/kg LY293558 vs. 6 mg subcutaneous sumatriptan vs. placebo i...
  Sang CM, Ramadan NM, Chappell AS, Freitag FG, Smith TR, Silberstein SD, Tepper SJ, Neurology 2001;56 (Suppl 3):A219
• Acute Treatment of Migraine: Issues of Disability and Early Intervention.
  Tepper SJ, Proceedings of the 15th Italian Society for the Study of Headache. Florence, Italy
• HIT-6 Scores Discriminate Among Headache Sufferers.
  Kosinski M, Garber WH, Diamond M, Tepper S, Bayliss MS, Bjorner JB, Batenhorst A, J Neurological Sciences 2001;187(Suppl 1):S13
• HIT-6 Reliably Measures the Impact of Headache.
  Garber WH. Kosinski M, Dahlof C, Tepper S, Kujawski SC, Bjorner JB, Batenhorst A, J Neurological Sciences 2001;187(Suppl 1):S122
• IV LY293558, an AMPA/KA antagonist, is effective in migraine.
  Ramadan N, Sang C, Chappell A, Vandenhende F, Johnson K, Phebus L, Bleakman D, Ornstein P, Arnold B, Freitag F, Smotih T, Silberstein S, Tepper S, Cephalalgia 2001;21:267
• Impact of migraine relative to other headache types.
  Tepper S, Dahlof C, Sheftell F, Dewey J, Batenhorst A, Cephalalgia 2001;21:331-332
• Join now to see all

Lectures

• Prevention of Headache Recurrence, Migraine. 
  American Academy of Neurology, Boston, MA
• Pathophysiology and Pharmacology of Migraine. 
  XVI Annual US Army Medical Department Neurology Conference. Madigan Army Medical Center, Tacoma, WA
• When should we use 5HT agonists and when might they be used in preference to other treatments such as ergotamines and combination therapies, in New Horizons in Migraine. 
  XVIth World Congress of Neurology, Buenos Aires, Argentina
• Pharmacologic Treatment of Primary Headache Disorders: Acute Strategies, in Headache: Management and Therapy. 
  XVIth World Congress of Neurology, Buenos Aires, Argentina
• Zolmitriptan in clinical practice - establishing the role of 5HT1B/1D receptor agonists in migraine. 
  XVIth World Congress of Neurology, Buenos Aires, Argentina
• Ergots and Migraine, Treatment of Migraine. 
  St John’s College, Cambridge University, Cambridge, England
• Epidemiology of Migraine and the Burden of Disease, The Causes of Migraine- Pathophysiology and the Triptans. 
  International Media Symposium, Warren House, London, England
• Maximizing Treatment Response to Acute Migraine Therapy. 
  American Association for the Study of Headache, San Francisco, CA
• Patient Reported Tablet Utilization of Zolmitriptan and Sumatriptan. 
  American Association for the Study of Headache, San Francisco, CA
• Tolerability of Sumatriptan Nasal Spray in the Acute Treatment of Migraine: A Review of Data from Clinical Trials. 
  American Association for the Study of Headache, San Francisco, CA
• Clinical Use of Zolmitriptan, ADITUS Medical Media Workshop II- New Migraine Treatments and Management Strategies. 
  NY Academy of Medicine, NY, NY
• Rational Migraine Management - Optimising Treatment with Zolmitriptan: What do Physicians Want? 
  3rd European Federation of Neurologic Societies, Seville, Spain
• ADITUS Medical Media Workshop III- New Migraine Treatments and Strategies 
  3rd European Federation of Neurologic Societies, Seville, Spain
• The new triptans (5-HT 1B/1D agonists) for acute treatment of migraine: a clinical review using number needed to treat (NNT) analysis. 
  3rd European Federation of Neurological Societies, Seville, Spain
• Migraine Research- Today and in the Future, and The Triptans- 1999 Comparative Review, at Changing the Face of Migraine. 
  St John’s College, Cambridge University, Cambridge, England
• Scientific Basis of Migraine, in Scientific Basis of Neurology I. 
  American Academy of Neurology, San Diego, CA
• Reducing the cost of impairment of Normal Activities due to Migraine: A Stratified-Care Approach. 
  American Headache Society, Montreal, Canada
• Pathophysiology of Migraine. 
  Yale University School of Medicine
• Migraine and Tension Type Headache. 
  Vanderbilt University Medical School, Nashville, TN
• Understanding Patient Preference, in Rizatriptan: Meeting the Needs of More Migraine Patients. 
  Headache World 2000, London, UK
• What do patients want in acute migraine treatment? 
  European Federation of Neurological Societies, Copenhagen, Denmark
• Clinical Headache Update. 
  Mexican Academy of Neurology Congress, Acapulco, Mexico
• Pathophysiology of Migraine. 
  Indiana University School of Medicine
• Triptan Clinical Efficacy, Clinical Endpoints, and Disability, in Addressing the Burdens of Migraine: Clinical and Treatment Strategies. 
  Mallorca, Spain, March 10, 2001, also with two workshops in Barcelona, Spain
• Optimizing Acute Therapy- A Case for Early Intervention in Treatment of Headache and Facial Pain. 
  NY Headache Foundation, NY, NY
• Join now to see all

Other

• Migraine: improved outcomes in patients previously poorly responsive to therapy. 
  Dowson AJ and Tepper SJ, Int J Clinic Practice 2008;62(12):1822-1824
• Rescue Me: Rescue Medication for Migraine. 
  Whyte C, Tepper SJ, Evans R, Headache 2010;50(2):307-313
• Adherence to Acute Migraine Medication: What Does It Mean, Why Does It Matter? 
  Katic´ BJ, Krause SJ, Tepper SJ, Hu HX, Bigal ME, Headache 2010;50(1):117-132
• How Do I Do It- Acute Treatment of Migraine. 
  Tepper SJ and Tepper DE, American Headache Society CME
  http://www.AmericanHeadacheSociety.org
• What is CGRP and What Should You Know About It? Answers to Why Everyone is Talking About CGRP Receptor Antagonists. 
  Tepper SJ, American Headache Society American Council on Headache Education (ACHE) Newsletter 2009;1(3):8-9
• Treatment and management of migraine- The Road Ahead. 
  Hutchinson SL and Tepper SJ, US Neurology, 2009;5(1):72-74
• Adverse Effects of Medications Commonly Used in the Treatment of Migraine. 
  Whyte C and Tepper SJ, Expert Review of Neurotherapeutics 2009;9(9):1379-1391
• Update on Menstrual Migraine. 
  Tepper SJ and Kriegler JS, The Female Patient, July 2009 ;34 (7):17-24
• Daily Pharmacologic Prophylaxis of Episodic Migraine. 
  Bamford CC and Tepper SJ, Techniques in Regional Anesthesia and Pain Management 2009;13(1): 20-37
• Commentary: How different is migraine prevalence among the races? 
  Tepper SJ, Headache 2009;49: 894
• Patent Foramen Ovale and Migraine: Association, Causation, and Implications of Clinical Trials. 
  Tepper SJ, Cleves C, Taylor FR, Current Pain and Headache Reports 2009;13:221–226
• Perimenstrual Migraines: Are They Different Than Migraines in General? 
  Tepper SJ, Current Pain and Headache Reports 2008; 12 (6):463-
• Pearls and “Oy-sters”: Trigeminal Autonomic Cephalalgias. 
  Whyte C and Tepper SJ, Neurology. 2010;74(11):e40-2
• Up-to-date pharmacologic options for managing headache pain. 
  Tepper SJ and Mays M, Medscape Neurology and Neurosurgery
• Complementary and Alternative Treatments for Childhood Headaches. 
  Tepper SJ, Current Pain and Headache Reports 2008, 12:379–383
• Clinical and Preclinical Rationale for CGRP Antagonists in the Treatment of Migraine. 
  Tepper SJ and Stillman MJ, Headache (Headache Currents) 2008;48:1259-1268
• Sumatriptan Naproxen Sodium Combination for the Acute Treatment of Migraine. 
  Cleves C, Tepper SJ, Expert Review of Neurotherapeutics 2008; 8(9), 1289–1297
• PFO and Migraine: Association and Causation. 
  Tepper SJ, Cleveland Clinic Neuroscience Pathways Fall/Winter 2008;16-17
• Recent Studies on PFO and Migraine: Is There a Future for Closure? 
  Taylor FR, Tepper SJ, Stillman MJ, Headache 2008;48(7):1083-1086
• Drug-Induced Serotonin Syndrome: A Review. 
  Sun-Edelstein C, Tepper SJ, Shapiro RE, Expert Opin. Drug Safety 2008: 7(5):1-10
• Evidence-based Basics on Nutraceuticals: Herbs, Minerals, Vitamins, and Supplements in Migraine Management. 
  Tepper SJ, Information for Health Care Professionals, American Headache Society
• A Pivotal Moment in 50 years of Headache History: The First American Migraine Study. 
  Tepper SJ, Headache 2008; 48:730-1
• Clinical Insights into Two Replicate Randomized Double-Blind, Placebo-Controlled Trials of the Time to onset of Pain Relief in the Acute Treatment of Migraine with a F... 
  Tepper SJ, Clinical Impressions Dec 2006;1:2-4
• Conclusions on Opioids. 
  Tepper SJ and Rothrock JF, Headache 2012; 52(S1):39-39
• Medication Overuse Headache: Clinical Considerations. 
  Mathew NT, Katsarava Z, Tepper SJ, Redenbach F, Porecca F, Chen S, Silberstein SD, Neurology
• Join now to see all